53 related articles for article (PubMed ID: 10779150)
1. Lipoxygenase inhibitor FLM 5011, an effective protectant of myocardial microvessels against ischemia-reperfusion injury? An ultrastructural-morphometric study.
Welt K; Fitzl G; Mark B
Exp Toxicol Pathol; 2000 Mar; 52(1):27-36. PubMed ID: 10779150
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of lipoxygenase inhibitor FLM 5011 on mitochondria ultrastructure of ischemic and reperfused cardiomyocytes.
Fitzl G; Winkler D; Wassilev G; Welt K
Exp Toxicol Pathol; 1999 May; 51(3):245-53. PubMed ID: 10334466
[TBL] [Abstract][Full Text] [Related]
3. [Coronary microcirculation in myocardial reperfusion. The phenomenon of no-reperfusion].
Jorge PA; Curti HV; Metze K
Arq Bras Cardiol; 1991 Jun; 56(6):471-6. PubMed ID: 1823748
[TBL] [Abstract][Full Text] [Related]
4. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits.
Rao Y; Wang YL; Zhang WS; Liu J
Anesth Analg; 2008 May; 106(5):1353-9, table of contents. PubMed ID: 18420844
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of iloprost, a PGL2 analogue, on ultratructure of ischemic and reperfused myocardial myocytes.
Fitzl G; Winkler D; Wassilev G; Welt K
Exp Toxicol Pathol; 1999 Jan; 51(1):81-8. PubMed ID: 10048718
[TBL] [Abstract][Full Text] [Related]
6. Changes in the microvasculature of ischemic and infarcted myocardium.
Armiger LC; Gavin JB
Lab Invest; 1975 Jul; 33(1):51-6. PubMed ID: 1142742
[TBL] [Abstract][Full Text] [Related]
7. Role of 5-lipoxygenase in myocardial ischemia-reperfusion injury in mice.
Adamek A; Jung S; Dienesch C; Laser M; Ertl G; Bauersachs J; Frantz S
Eur J Pharmacol; 2007 Sep; 571(1):51-4. PubMed ID: 17586489
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural basis of the free-radical scavenging effect of indapamide in experimental myocardial ischemia and reperfusion.
Mouhieddine S; Tresallet N; Boucher F; de Leiris J
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S47-52. PubMed ID: 7508061
[TBL] [Abstract][Full Text] [Related]
9. Reversible blockade of electron transport during ischemia protects mitochondria and decreases myocardial injury following reperfusion.
Chen Q; Moghaddas S; Hoppel CL; Lesnefsky EJ
J Pharmacol Exp Ther; 2006 Dec; 319(3):1405-12. PubMed ID: 16990510
[TBL] [Abstract][Full Text] [Related]
10. Microvasculature sparing with controlled reperfusion of ischemic myocardium.
Mrak RE; Murphy ML; Peng CF; Straub KD
Am J Cardiovasc Pathol; 1990; 3(3):253-8. PubMed ID: 2095831
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of ischemia/reperfusion injury in isolated rats hearts by the ATP-sensitive potassium channel opener BMS-180448.
Monticello TM; Sargent CA; McGill JR; Barton DS; Grover GJ
Cardiovasc Res; 1996 Jan; 31(1):93-101. PubMed ID: 8849593
[TBL] [Abstract][Full Text] [Related]
12. Coronary vascular injury due to ischemia-reperfusion is reduced by pentoxifylline.
Dauber IM; Lesnefsky EJ; Ashmore RC; Martel DM; Sheridan FM; Weil JV; Horwitz LD
J Pharmacol Exp Ther; 1992 Mar; 260(3):1250-6. PubMed ID: 1312165
[TBL] [Abstract][Full Text] [Related]
13. Effects of the arachidonate 5-lipoxygenase synthesis inhibitor A-64077 in intestinal ischemia-reperfusion injury.
Mangino MJ; Murphy MK; Anderson CB
J Pharmacol Exp Ther; 1994 Apr; 269(1):75-81. PubMed ID: 8169854
[TBL] [Abstract][Full Text] [Related]
14. Vasculoprotective effect of insulin in the ischemic/reperfused canine heart: role of Akt-stimulated NO production.
Ma H; Zhang HF; Yu L; Zhang QJ; Li J; Huo JH; Li X; Guo WY; Wang HC; Gao F
Cardiovasc Res; 2006 Jan; 69(1):57-65. PubMed ID: 16212952
[TBL] [Abstract][Full Text] [Related]
15. Coronary endothelial cells: a target of ischemia reperfusion and its treatment?
Laude K; Richard V; Thuillez C
Arch Mal Coeur Vaiss; 2004 Mar; 97(3):250-4. PubMed ID: 15106748
[TBL] [Abstract][Full Text] [Related]
16. [Effects of insulin on cardiac function and coronary circulation in acute myocardial ischemia and reperfusion experiment with dogs].
Ma H; Huo JH; Zhang HX; Bian JF; Wang YM; Xiong LZ; Guo WY; Wang HC; Gao F
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3128-32. PubMed ID: 17313765
[TBL] [Abstract][Full Text] [Related]
17. Antiinflammatory effect of a lipoxygenase inhibitor (FLM 5011) in severe active myocarditis.
Geissler W; Förster A; Schewe T; Rapoport SM; Slapke J; Meyer R; Romaniuk P; Reisinger I
Biomed Biochim Acta; 1988; 47(10-11):S311-4. PubMed ID: 3150273
[TBL] [Abstract][Full Text] [Related]
18. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury.
Buerke M; Prüfer D; Dahm M; Oelert H; Meyer J; Darius H
J Pharmacol Exp Ther; 1998 Jul; 286(1):429-38. PubMed ID: 9655888
[TBL] [Abstract][Full Text] [Related]
19. [Ultrastructure of the microcirculatory bed of the myocardium in coronary insufficiency].
Gavrish AS
Arkh Patol; 1979; 41(4):48-54. PubMed ID: 444088
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of a new 5-lipoxygenase inhibitor on occlusion- and occlusion-reperfusion-induced myocardial injury.
Hashimoto H; Miyazawa K; Hagiwara M; Miyasaka K; Nakashima M
Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):126-9. PubMed ID: 2334452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
